Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy
出版年份 2015 全文链接
标题
Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 5, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-10-26
DOI
10.3389/fonc.2015.00240
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DNA Damage in Cancer Therapeutics: A Boon or a Curse?
- (2015) Anchit Khanna CANCER RESEARCH
- DNA-PKcs plays role in cancer metastasis through regulation of secreted proteins involved in migration and invasion
- (2015) Ewa Kotula et al. CELL CYCLE
- Differential Phosphorylation of DNA-PKcs Regulates the Interplay between End-Processing and End-Ligation during Nonhomologous End-Joining
- (2015) Wenxia Jiang et al. MOLECULAR CELL
- CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro
- (2015) G Xi et al. ONCOGENE
- The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis
- (2015) Nicholas Jette et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63
- (2015) Xin Li et al. TUMOR BIOLOGY
- Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy
- (2015) Rebecca Lamb et al. Oncotarget
- NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor
- (2015) Lan Yu et al. Oncotarget
- DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
- (2015) Euan A. Stronach et al. NEOPLASIA
- Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity
- (2014) Emily Mould et al. BIOCHEMICAL PHARMACOLOGY
- Opportunities for translation: Targeting DNA repair pathways in pancreatic cancer
- (2014) Elaina N. Maginn et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The role of DNA repair pathways in cisplatin resistant lung cancer
- (2014) Shane O’Grady et al. CANCER TREATMENT REVIEWS
- DNA-PK--A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival
- (2014) L. Cornell et al. CLINICAL CANCER RESEARCH
- 3 Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancer
- (2014) S. Blagden et al. EUROPEAN JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Co-targeting Deoxyribonucleic Acid–Dependent Protein Kinase and Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Promotes Accelerated Senescence of Irradiated Cancer Cells
- (2014) Arun Azad et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
- (2014) Nada Albarakati et al. Molecular Oncology
- Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair
- (2014) Ann-Sofie Gustafsson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy
- (2014) Melvin Lee Kiang Chua et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
- (2014) J. M. Cunningham et al. Scientific Reports
- A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma
- (2014) Julian Biau et al. NEOPLASIA
- BRCA and Early Events in the Development of Serous Ovarian Cancer
- (2014) Sophia H. L. George et al. Frontiers in Oncology
- Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
- (2014) W. Ruprecht Wiedemeyer et al. Frontiers in Oncology
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
- (2013) Wojciech M. Ciszewski et al. BREAST CANCER RESEARCH AND TREATMENT
- Understanding pancreatic cancer genomes
- (2013) Mark J. Cowley et al. Journal of Hepato-Biliary-Pancreatic Sciences
- 1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity
- (2013) Céline Cano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody
- (2013) H. Song et al. MOLECULAR CANCER THERAPEUTICS
- Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441
- (2013) Ales Tichy et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- Identification of genes with a correlation between copy number and expression in gastric cancer
- (2012) Lei Cheng et al. BMC Medical Genomics
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation Response
- (2012) Ying-Hua Li et al. PLoS One
- Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
- (2011) Michele Tavecchio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells
- (2011) Xiaoyuan Huang INTERNATIONAL JOURNAL OF ONCOLOGY
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- DNA-Dependent Protein Kinase and Ataxia Telangiectasia Mutated (ATM) Promote Cell Survival in Response to NK314, a Topoisomerase II Inhibitor
- (2011) L. Guo et al. MOLECULAR PHARMACOLOGY
- Choosing the right path: Does DNA-PK help make the decision?
- (2011) Jessica A. Neal et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer
- (2011) Fadhel S. Shaheen et al. PLoS One
- Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
- (2011) Cheryl A Sherman-Baust et al. Journal of Ovarian Research
- Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia
- (2010) Sarah L. Elliott et al. BRITISH JOURNAL OF HAEMATOLOGY
- DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells
- (2010) Prakash Peddi et al. FREE RADICAL BIOLOGY AND MEDICINE
- DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype
- (2010) Céline Cano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
- (2010) F Al-Ejeh et al. ONCOGENE
- Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities
- (2010) Langland ONCOLOGY REPORTS
- Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma
- (2009) W. Sakai et al. CANCER RESEARCH
- Histologic Subtypes of Ovarian Carcinoma
- (2009) Robert A. Soslow INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
- (2009) M -A Westhoff et al. ONCOGENE
- Activation of DNA-PK by Ionizing Radiation Is Mediated by Protein Phosphatase 6
- (2009) Jun Mi et al. PLoS One
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia
- (2008) E. Willmore et al. CLINICAL CANCER RESEARCH
- A mechanism for DNA-PK activation requiring unique contributions from each strand of a DNA terminus and implications for microhomology-mediated nonhomologous DNA end joining
- (2008) Katherine S. Pawelczak et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search